A carregar...
A synopsis of recent developments defining how N-glycosylation impacts immunoglobulin G structure and function
Therapeutic monoclonal antibodies (mAbs) are the fastest growing group of drugs with 11 new antibodies or antibody-drug conjugates approved by the Food and Drug Administration in 2018. Many mAbs require effector function for efficacy, including antibody-dependent cell-mediated cytotoxicity triggered...
Na minha lista:
| Publicado no: | Glycobiology |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7109350/ https://ncbi.nlm.nih.gov/pubmed/31822882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/glycob/cwz068 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|